Story perspectives

CVS Earnings Plunge 44%, But Stock Soars 14%

2/12/2025

34 3

Summary

Story summary

CVS Health's Q4 2024 earnings fell to $1.19 per share, a 44% decrease year-over-year, with revenue rising 4% to $97.7 billion.
The company projects adjusted EPS between $5.75 and $6.00 for 2025, despite challenges in its Health Care Benefits segment.
Following the earnings report, CVS's stock increased over 14%, indicating strong investor confidence during the CEO transition.
Full-year profits declined to $4.6 billion from $8.3 billion in 2023, with total revenue for 2024 at $372.8 billion.

History

Historical Context

CVS Health's recent earnings drop echoes the challenges faced by major corporations during economic downturns, similar to the 2008 financial crisis. Back then, companies struggled with profitability amid rising costs and shifting consumer behaviors. CVS's stock rise amidst CEO transition suggests investor optimism, reminiscent of past recoveries following leadership changes.

1 of 2

Story summary

CVS Health's Q4 2024 earnings fell to $1.19 per share, a 44% decrease year-over-year, with revenue rising 4% to $97.7 billion.
The company projects adjusted EPS between $5.75 and $6.00 for 2025, despite challenges in its Health Care Benefits segment.
Following the earnings report, CVS's stock increased over 14%, indicating strong investor confidence during the CEO transition.
Full-year profits declined to $4.6 billion from $8.3 billion in 2023, with total revenue for 2024 at $372.8 billion.

1 / 2